Lu Zhang
Founder & Managing Partner @ Fusion Fund
Palo Alto, United States
Lu Zhang is a seed investor at Fusion Fund in Palo Alto focused on Artificial Intelligence and Software. Lu Zhang, Founder and Managing Partner of Fusion Fund. Recently, Lu was selected as one of the 2018 Young Global Leaders by the World Economic Forum (Davos). Prior to this, she also got selected as Silicon Valley Women of Influence 2018 and Top 10 all America Chinese Youth. In 2017, she was awarded the Forbes US 30 under 30 & Featured Honoreeof VC category and also awarded as the Town & Country 50 Modern Swans Influencer. Prior to starting Fusion Fund, she was the Founder and CEO of a medical device company (acquired in 2012). Lu is active in the entrepreneur and investor communities providing mentorship and serves as an advisor to programs like Microsoft AC, Singularity University, StartX at Stanford, and Youth Council of Future Forum. Lu received her M.S. in Materials Science and Engineering from Stanford University and holds several patents.
- Total investments:
- 77
- Last investment:
- Lead investor:
- 19%
Last updated:
For AI agents: llms.txt
Industries Lu Zhang invests in
Stages Lu Zhang invests in
Countries Lu Zhang invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Artificial Intelligence 19 (25%)
- Software 15 (19%)
- Health Care 9 (12%)
- Medical 8 (10%)
- Machine Learning 8 (10%)
Stage
- Seed 32 (42%)
- Series A 15 (19%)
- Funding Round 10 (13%)
- Series B 4 (5%)
- Series C 3 (4%)
Country
- United States 51 (66%)
- Canada 1 (1%)
- United Kingdom 1 (1%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Subtle Medical
|
Subtle Medical is a healthcare technology company that provides AI-powered medical imaging. Its products, SubtlePET and SubtleMR, are FDA Cleared and CE Marked AI product that enhances images in PET and MR exams aimed for faster & safer workflow.The company's SubtleGAD technology is also awarded by RSNA and a $1.6M NIH SBIR Grant tofacilitate the adoption using AI to make imaging exams safer. They provide a vendor-agnostic AI infrastructure powering its products and providing service and analytics to clinical imaging providers.Subtle Medical's goal is to improve the quality, value, and accessibility of medical imaging by significantly reducing cost, imaging time, and radiation dose. | $33M / Series C / Jun 02, 2026 | |
Portal26
|
Titaniam offers a platform that according to the company renders data immune to ransomware, cyberattacks, extortion, insider threats, accidental exposure and any data-related cyber event. | $9M / Series A / Nov 04, 2025 | |
Reality Defender
|
Reality Defender is the market leader in deepfake detection, protecting enterprises and governments from realtime deepfake and agentic fraud. Sign up for free access at https://www.realitydefender.com/apiAwards: 2025 - Gartner: Recognized as Market Leader in Deepfake Detection 2025 - JPMorgan: Inducted into Hall of Innovation 2025- World Economic Forum: Named Technology Pioneer 2025 - USA DIU + Japan MOD: 1st Place "Global Innovation Challenge" 2024 - RSA Conference: 1st Place “Most Innovative Startup” 2024 - SINET16 Innovator Award 2023 - SXSW 1st Place "Artificial Intelligence, Voice, & Robotics Technologies" | $85.6K / Venture - Series Unknown / Apr 03, 2025 | |
Proscia
|
Proscia is a software company that is changing the way the world practices pathology to transform cancer research and diagnosis. With the company’s Concentriq digital pathology platform and pipeline of AI-powered applications, laboratories are leveraging new kinds of data to accelerate discoveries and improve patient outcomes. Proscia’s team oftechnologists, scientists, and pathologists is bringing a fresh approach to an outdated industry, helping the world to keep pace with the increasing demand for pathology services and fulfill the promise of precision diagnostics. | $50M / Series D / Mar 19, 2025 | |
SAIF Autonomy
|
At SAIF Systems we aim to be the global leaders in novel control assurance, pioneering trusted and ethical autonomy for humanity. Our software enables assured, trustworthy deployment of AI and novel control in any application for the first time; starting with autonomous systems.SAIF offers licensing and SaaS development options to OEMs, systemintegrators, operators, and regulators, ultimately ensuring safety in autonomous systems everywhere. | $1.2M / Pre-Seed / Feb 14, 2025 | |
Starpath Robotics
|
Starpath Robotics builds spacecraft propellant that reduces the deep space transport cost. | $12M / Seed / Aug 20, 2024 | |
|
Subtle Medical
|
Subtle Medical is a healthcare technology company that provides AI-powered medical imaging. Its products, SubtlePET and SubtleMR, are FDA Cleared and CE Marked AI product that enhances images in PET and MR exams aimed for faster & safer workflow.The company's SubtleGAD technology is also awarded by RSNA and a $1.6M NIH SBIR Grant tofacilitate the adoption using AI to make imaging exams safer. They provide a vendor-agnostic AI infrastructure powering its products and providing service and analytics to clinical imaging providers.Subtle Medical's goal is to improve the quality, value, and accessibility of medical imaging by significantly reducing cost, imaging time, and radiation dose. | $10M / Series B / May 13, 2024 | |
|
Proscia
|
Proscia is a software company that is changing the way the world practices pathology to transform cancer research and diagnosis. With the company’s Concentriq digital pathology platform and pipeline of AI-powered applications, laboratories are leveraging new kinds of data to accelerate discoveries and improve patient outcomes. Proscia’s team oftechnologists, scientists, and pathologists is bringing a fresh approach to an outdated industry, helping the world to keep pace with the increasing demand for pathology services and fulfill the promise of precision diagnostics. | $9M / Series C / Mar 13, 2024 | |
Talofa
|
Talofa is building games that make players mentally and physically healthier. Their flagship game on the platform, Run Legends, got over 300,000 downloads in the first 3 months and was featured as one of the "Best New Games" by Apple and Google Play Stores. Talofa’s team has been built up with game veterans from EA, 2K, and Riot Games andthe CEO, Jenny Xu, has created mobile games with over 10M downloads. | $6.3M / Seed / Jan 18, 2024 | |
Mojo Vision
|
Mojo Vision is a developer of augmented reality products and platforms intended to invent the future of computing. The company has developed a smart contact lens with a built-in display that gives timely information without interrupting the focus and delivers immediate, powerful, and relevant information without the intrusions of today'smobile devices, enabling users to connect with others at a glance, anytime, anywhere handsfree.Mojo Vision was founded in 2015 and headquartered in Saratoga, California. | $43.5M / Series A / Oct 12, 2023 | |
| See all 77 investments → | |||
Co-Investors
About Fusion Fund
Fusion Fund supports early-stage entrepreneurs who are looking to build globally disruptive companies using innovative technologies to drive systemic change.They are entering the next wave of technological advancement and foundational innovation is required to enable massive growth. With Fusion Fund’s technical and entrepreneurial backgrounds,we seek to support entrepreneurs who are building companies with strong technical barriers and advantages in their business models.
Fusion Fund Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Blake Pennington
Senior Associate
|
|||
Kevin Zhang
Associate
|
|||
|
Lu Zhang
Founder & Managing Partner
|
|||
Vicky O’Hara
Chief Financial Officer
|
|||
Zhenan Bao
Advisory Partner
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Lu Zhang invest in?
Lu Zhang invests primarily in Artificial Intelligence, Software and Health Care startups, most often at Seed and Series A stage. Most of the 77 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Lu Zhang?
Public channels for Lu Zhang include LinkedIn and X (Twitter). For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Lu Zhang last invest?
The most recent investment recorded for Lu Zhang closed in Jun 2026. Shizune tracks 77 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Sep 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
